INS and amelogenesis imperfecta type 1G: In particular, c-jun N-terminal kinase (JNK) and I kappa β kinase (IKKβ) are associated with ERS and act as inhibitors of insulin signaling, based on the fact that activation of IKKβ aggravates ERS and impaired insulin signaling [90,91].